RPI-78M (Nutra Pharma / ReceptoPharm)

Nutra Pharma Announces Completion of Clinical Study in ...
Business Wire (press release) - San Francisco,CA,USA
“Completing this clinical trial is an important achievement for both Nutra Pharma and ReceptoPharm,” commented Paul Reid, CEO of ReceptoPharm. ...
See all stories on this topic

 

 

 

Yale Researchers Find New Trigger For Autoimmune Diseases
Yale University researchers have discovered a new way that autoimmune diseases like multiple sclerosis (MS) can be triggered, they reported Monday in the journal Proceedings of the National Academy of Sciences.

---

 

 

Smoking worsens the prognosis in multiple sclerosis

In this second paper on smoking and MS the authors found links with a worse clinical course.

authors: Sundström P, Nyström L.

source: Mult Scler. 2008 Jul 16. [Epub ahead of print]

read more

 

 

Smoking is a risk factor for early conversion to clinically definite multiple sclerosis

In this study the authors looked at people who had one attack suggestive of MS. They found that having a second attack was more common in people who smoked. The importance of the study is that smoking is a modifiable risk factor.

authors: Di Pauli F, Reindl M, Ehling R, Schautzer F, Gneiss C, Lutterotti A, O'Reilly EJ, Munger KL, Deisenhammer F, Ascherio A, Berger T.

source: Mult Scler. 2008 Jul 16.

read more

---

 

Acorda Therapeutics to Host Conference Call to Report Second ...
Genetic Engineering News (press release) - New Rochelle,NY,USA
Acorda's lead clinical product, Fampridine-SR, recently completed a second Phase 3 clinical trial to evaluate its safety and efficacy in improving walking ...
See all stories on this topic

 

 

Acorda Therapeutics to Host Conference Call to Report Second ...
Business Wire (press release) - San Francisco,CA,USA
Acorda’s lead clinical product, Fampridine-SR, recently completed a second Phase 3 clinical trial to evaluate its safety and efficacy in improving walking ...
See all stories on this topic

 

 

Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis

This paper found that loss of brain and cord tissue in people with secondary progressive MS is associated with a more severe clinical course. They suggested that MRI measures of atrophy may therefore be useful in future clinical trials.

authors: Furby J, Hayton T, Anderson V, Altmann D, Brenner R, Chataway J, Hughes RA, Smith KJ, Miller DH, Kapoor R.

source: Mult Scler. 2008 Jul 16.

read more

---

Regenerative medicine

 

Repair Stem Cell Institute Announces Top Global Stem Cell ...
Trading Markets (press release) - Los Angeles,CA,USA
One successful patient outcome is a professional golfer who had been diagnosed with multiple sclerosis. After receiving a repair stem cell treatment using ...
See all stories on this topic

 

 

Repair Stem Cell Institute Announces Top Global Stem Cell ...
istockAnalyst.com - Salem,OR,USA
One successful patient outcome is a professional golfer who had been diagnosed with multiple sclerosis. After receiving a repair stem cell treatment using ...
See all stories on this topic

 

 

ALS Therapy Development Institute and California Stem Cell, Inc ...
Earthtimes (press release) - London,UK
This effort is the latest in the two groups' on-going partnership to understand how stem cells, and their derivatives, may be used as part of a therapeutic ...
See all stories on this topic

 

 

New And Potentially Better Source Of Platelets For Transfusion
Clot-forming blood cells, or platelets, can drop to dangerously low levels in diseases such as anemia and in patients undergoing chemotherapy. To replace these critical cells, doctors filter platelets from donated blood, but this approach can increase the risk of transmitting blood infections and cause other side effects in patients who need frequent transfusions.

---

 

 

Statins Linked To Lower Dementia Risk
A US study that followed over 1,500 older Mexican Americans for 5 years found that statin users were about half as likely to develop dementia, or to have cognitive impairment without dementia, as those who did not use statins.

 

 

Alzheimer's Society Comment On Research Into Statins And Dementia
Statins are increasingly hitting the headlines as a potential cure for dementia. The jury is still out on how effective they are, but this study adds to growing evidence that they may have some benefits.

 

 

Drugs Commonly Used For Erectile Dysfunction Allowed More Chemotherapy To Reach Brain Tumors In Laboratory Animal Study
In a study using laboratory animals, researchers found that medications commonly prescribed for erectile dysfunction opened a mechanism called the blood-brain tumor barrier and increased delivery of cancer-fighting drugs to malignant brain tumors.

 

 

Steep Rise In At Home Deaths As Patients Fail To Manage Their Medications
The sad loss of 28-year old movie actor Heath Ledger in January this year, who died from an accidental overdose of a prescription drug, brought to public attention the potential dangers of patients managing their own medications, which when combined with alcohol and street drugs, has resulted in a more than 3,000 per cent rise in home deaths due to medication errors, said US researchers in a new study.